The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.

ABSTRACT:

Purpose

To review all studies reporting the onset of white dot syndromes following COVID-19 vaccines.

Methods

Our protocol was registered prospectively on PROSPERO [registration number: CRD42023426012]. We searched five different databases including PubMed, Scopus, Web of Science, Google Scholar, and Science Direct up to May 2023. All the studies that reported the occurrence of white dot syndrome following COVID-19 vaccines were included. All statistical tests were conducted with a 95% confidence interval and a 5% error margin. A p value of less than 0.05 was considered statistically significant. The methodological quality of included studies was performed using the IHE Quality Appraisal Checklist for Case Series studies and JBI Critical Appraisal Checklist for Case Reports.

SUBMITTER: Abu Serhan H 

PROVIDER: S-EPMC11039548 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature